These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3017644)

  • 1. [Correlation of HSV-2-induced early antigen with antibodies from cervical carcinoma patients].
    Jiang JW
    Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):107-9, 126. PubMed ID: 3017644
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody to herpes simplex virus type 2-induced early antigens and its radioimmunoassay with sera of cervical carcinoma patients.
    Ito H; Kurihara S; Nishimura C
    Kitasato Arch Exp Med; 1978 Jun; 51(1-2):1-13. PubMed ID: 225600
    [No Abstract]   [Full Text] [Related]  

  • 5. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 6. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
    Aurelian L; Cornish JD; Smith MF
    IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
    Adelusi B; Osunkoya BO; Fabiyi A
    Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
    Aurelian L
    Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 10. Herpesvirus hominis: from latency to carcinogenesis?
    Aurelian L
    Johns Hopkins Med J Suppl; 1973; 2():245-66. PubMed ID: 4137697
    [No Abstract]   [Full Text] [Related]  

  • 11. A geographical study of antibodies to membrane antigens of HSV-2-infected cells and HSV-2-specific antibodies in patients with cervical cancer.
    Mendis LN; Best JM; Senarath L; Chiphangwi J; Vestergaard BF; Banatvala JE
    Int J Cancer; 1981 Nov; 28(5):535-42. PubMed ID: 6273337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of RNA complementary to herpes simplex virus DNA in human cervical squamous cell neoplasms.
    Eglin RP; Sharp F; MacLean AB; Macnab JC; Clements JB; Wilkie NM
    Cancer Res; 1981 Sep; 41(9 Pt 1):3597-603. PubMed ID: 6167349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-immunological investigations in patients with cervical cancer: higher rate of HSV-2 antibodies than in syphilis patients and evidence of IgM antibodies to an early HSV-1 antigen.
    Schneweis KE; Haag A; Lehmköster A; Koenig U
    IARC Sci Publ (1971); 1975; (11 Pt 2):53-7. PubMed ID: 191383
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virions and antigens of herpes virus type 2 in cervical carcinoma.
    Aurelian L
    Cancer Res; 1973 Jun; 33(6):1539-47. PubMed ID: 4352393
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients.
    Heise ER; Kucera LS; Raben M; Homesley H
    Cancer Res; 1979 Oct; 39(10):4022-6. PubMed ID: 225014
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of herpes simplex-associated antigens and antibodies in patients with cervical carcinoma in Buenos Aires.
    Teyssié AR; Ayerra de Holstein B; Alonio L; Distéfano A; Lucero J; Pasqualini RS; de Torres RA
    Cell Mol Biol Incl Cyto Enzymol; 1980; 26(2):123-7. PubMed ID: 6258793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoenzymatic detection of IgA and IgG antibodies to HSV-1, HSV-2 in sera of patients with cervical cancer (author's transl)].
    Fan J; Zeng Y; Liu YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Feb; 4(1):50-2. PubMed ID: 6279319
    [No Abstract]   [Full Text] [Related]  

  • 19. Class-specific antibodies (IgG and IgA) to membrane antigens of Herpes simplex type 2-infected cells in patients with cervical dysplasia and neoplasia.
    Mendis LN; Best JM; Banatvala JE
    Int J Cancer; 1981 May; 27(5):669-77. PubMed ID: 6270022
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of seroepidemiological studies of herpesvirus type 2 and carcinoma of the cervix.
    Rawls WE; Adam E; Melnick JL
    Cancer Res; 1973 Jun; 33(6):1477-82. PubMed ID: 4352385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.